BioNTech CEO Uğur Şahin reports disposal of USD 6.24 million in common shares
BioNTech CEO Ugur Sahin sold 64,000 ordinary shares on Sept. 17-18, 2026 at USD 96.22 to USD 98.6. Direct holdings fell to 489,209 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and